Literature DB >> 21204821

Antiepileptic drugs, sex hormones, and PCOS.

Alberto Verrotti1, Claudia D'Egidio, Angelika Mohn, Giangennaro Coppola, Pasquale Parisi, Francesco Chiarelli.   

Abstract

Reproductive endocrine dysfunction in women with epilepsy is an important issue, and in recent years there is growing evidence to support the effect on sex hormones of both epilepsy per se and various antiepileptic drugs (AEDs). Focal epileptic discharges from the temporal lobe may have a direct influence on the function of the hypothalamic-pituitary axis, thereby altering the release of sex steroid hormones. The role of laterality and severity of epilepsy is still conflicting. The use of the liver enzyme-inducing AEDs--such as phenobarbital, phenytoin, and carbamazepine--can increase serum sex hormone-binding globulin concentrations, leading to diminished bioactivity of testosterone (T) and estradiol. Valproic acid, an enzyme inhibitor, has been associated with the occurrence of reproductive endocrine disorders characterized by high serum T, free androgen index, androstenedione, dehydroepiandrosterone sulfate concentrations, and with polycystic changes in ovaries and menstrual disorders. A better understanding of the effects of AEDs on sex hormones is key to selecting the appropriate AEDs and is crucial for reproductive health in female patients. Wiley Periodicals, Inc.
© 2010 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21204821     DOI: 10.1111/j.1528-1167.2010.02897.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  18 in total

Review 1.  Functional hypothalamic and drug-induced amenorrhea: an overview.

Authors:  A Lania; L Gianotti; I Gagliardi; M Bondanelli; W Vena; M R Ambrosio
Journal:  J Endocrinol Invest       Date:  2019-02-11       Impact factor: 4.256

Review 2.  Management of adverse effects of mood stabilizers.

Authors:  Andrea Murru; Dina Popovic; Isabella Pacchiarotti; Diego Hidalgo; Jordi León-Caballero; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

3.  Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.

Authors:  Aleisha M Moore; Mel Prescott; Christopher J Marshall; Siew Hoong Yip; Rebecca E Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-30       Impact factor: 11.205

4.  The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.

Authors:  Angel L Montejo; Laura Montejo; David S Baldwin
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

Review 5.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

Review 6.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

7.  Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.

Authors:  Ming Yang; David J Kozminski; Lindsey A Wold; Rohan Modak; Jeffrey D Calhoun; Lori L Isom; William J Brackenbury
Journal:  Breast Cancer Res Treat       Date:  2012-06-08       Impact factor: 4.872

8.  Preventive agents for migraine: focus on the antiepileptic drugs.

Authors:  R Shahien; K Beiruti
Journal:  J Cent Nerv Syst Dis       Date:  2012-02-26

9.  Identifying and treating the prodromal phases of bipolar disorder and schizophrenia.

Authors:  Susan Conroy; Michael Francis; Leslie A Hulvershorn
Journal:  Curr Treat Options Psychiatry       Date:  2018-01-22

10.  Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy.

Authors:  Guanzhong Ni; Jiaming Qin; Hongliang Li; Ziyi Chen; Yafang Zhou; Ziyan Fang; Yishu Chen; Jueqian Zhou; Min Huang; Liemin Zhou
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.